Zaluvida is a venture builder committed to catalyzing transformational change in human and planetary health. We incubate, invest in, and build alongside science-led ventures — offering not just capital, but clarity, care, and co-creation.
For nearly two decades, we built pioneering businesses that were ahead of their time — from world-first obesity treatments to antibiotic alternatives, from hay fever breakthroughs to solutions that reduce livestock emissions. These weren't just products; they were quiet revolutions.
Always Have. Always Will.
Today, our focus has shifted. We're no longer the sole drivers. We are strategic partners — hands-on, deeply embedded, and fiercely committed to the ventures we support. We build the runway, fuel the take-off, and help steer the climb.
Advanced Wound Care
From care to cure — pioneering pharmaceutical wound care
Rare Skin Disorders
First-in-class treatments for keratin disorders
Sustainable Agriculture
Making agriculture more sustainable — tackling climate impact and antimicrobial resistance from antibiotic overuse in animal protein production
Consumer Health
Health activation across root-cause disease areas
Health Innovation Services
Activating the world's healing potential
AI / Technology
AI-powered platform for autonomous ventures
20+
Years of innovation
15B+
Doses of accessible self-care
6
Active ventures
50+
Countries reached
We also apply our capital and expertise in not-for-profit settings — supporting global NGOs, humanitarian efforts, and education institutions to help millions thrive. Whether modernizing governance, backing frontline aid, or enabling ethical leadership, our aim is the same: to create lasting, positive change.
"We believe that what's good for people and planet can be good business too."
While others were just beginning to see the problem, we were already delivering answers. Our story is one of quiet revolutions — pioneering entire new markets, creating new categories, and reshaping existing ones.
Zaluvida is founded by Thomas Hafner and Carin Beumer in Singapore. First operations commence in Kuala Lumpur with just one staff member — and a bold vision to tackle the world's greatest health challenges.
We launch Liposinol — the first Class II Medical Device Certification for a substance-based, oral obesity treatment in the world. Within a month of signing our first distributor, the first order ships.
Outright market leader in solid-dose obesity treatments in Germany. More than 60 million tablets sold in a single year. A second world-first certification follows with PhaseLite.
We enter a strategic alliance with Omega Pharma NV for commercialisation across Greater Europe. Our gastrointestinal product range achieves regulatory approval.
We acquire exclusive rights to Neem Biotech's patented allicin/ajoene technology — a visionary decision for Zaluvida's future. We surpass 500 million tablets sold per annum. The team crosses 100 employees.
Prevalin is voted 'Product of the Year' by UK pharmacists and becomes a top-three treatment on the UK hay fever market. Our obesity range outsells competitors by more than 4 to 1.
Sale of the European obesity and allergy business to Omega Pharma for a net value of €141 million. The team grows to 250+ people. We surpass 1 billion tablets sold per annum.
Neem Biotech's state-of-the-art facility opens, officiated by the Welsh Minister. Zaluvida becomes the main financial constituent of HealthNet TPO, a global NGO serving tens of millions in crisis zones.
FDA grants orphan drug designation for our groundbreaking cystic fibrosis treatment. We acquire LiveExtract technology — Grazexin — a highly effective natural alternative to antibiotics for production animals. Mootral is founded and launched at COP 22 in Marrakech — the first viable solution to reduce methane emissions from ruminants. Mootral goes on to pioneer the world's first carbon credits from methane mitigation in livestock, creating an entire new category from scratch.
Zaluvida evolves from a holding group into a dynamic venture vehicle. The focus shifts from direct product innovation to strategic investment, mentorship, and enabling support for visionary founders.
As Zaluvida Ventures, we channel everything we've learned into helping new ventures succeed faster, scale smarter, and create impact that lasts. With more than 15 billion doses of accessible self-care delivered across 50+ countries, six active ventures, and a legacy of pioneering entire new markets — from advanced wound care and novel therapeutics to sustainable agriculture and AI — we build the conditions where others shine.
Always Have. Always Will.
Now, as a venture builder, we channel all we've learned into helping new ventures succeed faster, scale smarter, and create impact that lasts.
Each venture in our portfolio was selected — or created — because it addresses a fundamental challenge in human or planetary health. We don't just invest; we build alongside, embedding our experience, networks, and strategic counsel.
Advanced Wound Care
Onya Therapeutics is pioneering the shift from wound care to wound cure. Through its proprietary Active Edge Technology (AET) and lead candidate OTX-PP01, Onya is developing pharmaceutical-grade wound treatments that don't just manage chronic wounds — they activate the body's own healing response. With chronic wounds affecting over 2.5% of the US population and costing healthcare systems billions annually, Onya is addressing one of medicine's most overlooked epidemics.
onya.bio
Rare Skin Disorders
Mariposa Therapeutics is developing first-in-class treatments for keratin disorders — a group of rare, debilitating skin conditions with no approved therapies. By targeting the underlying biology of keratinization, Mariposa aims to transform the treatment landscape for patients who have been overlooked by traditional pharmaceutical development. The company represents Zaluvida's commitment to pursuing meaningful science where the need is greatest, not just where the market is largest.
mariposa.health
Sustainable Agriculture
Avanterra is making agriculture more sustainable — reducing its climate impact and addressing antimicrobial resistance driven by antibiotic overuse in animal protein production. The company tackles some of the most pressing environmental challenges at the intersection of agriculture, climate, and health, continuing Zaluvida’s pioneering legacy in planetary health.
avanterra.io
Consumer Health
InQpharm is a global consumer health company delivering clinically proven, IP-protected solutions across root-cause disease areas. With a portfolio spanning obesity, gastrointestinal health, allergy, and general health activation, InQpharm develops science-backed products that help people take control of their wellbeing. The company's treatments have reached patients in more than 50 countries, with over 15 billion doses sold — a testament to the power of combining rigorous science with accessible self-care.
inqpharm.com
Health Innovation Services
InQLABS is the innovation engine that helps the health industry activate the world's healing potential. As a consumer health R&D accelerator, InQLABS drives the development of next-generation compounds, formulations, and delivery systems across human health. From ideation through regulatory approval and commercialisation, InQLABS provides the scientific expertise, clinical infrastructure, and strategic guidance that transforms promising discoveries into products that reach patients. We've got you covered.
inqlabs.io
AI / Technology
OpenServ is an AI-powered platform that enables anyone to build, launch, and run autonomous ventures using AI agents. With its proprietary SERV reasoning framework and app launchpad, OpenServ is democratizing entrepreneurship — making it possible for a billion people to create and operate businesses that were previously only accessible to those with deep technical and financial resources. It represents Zaluvida's conviction that the future of venture building itself will be transformed by artificial intelligence.
openserv.aiThese ventures represent the foundation of our experience — the lessons, the breakthroughs, and the pioneering spirit that defined our journey.
A leading CRO and consultancy in consumer health. Pioneered regulatory and clinical research services for natural health products across Europe, supporting hundreds of clients from product conception through to market entry. Now part of the Biofortis Group.
a-r.com
A true pioneer in sustainable agriculture. Mootral was the first to deliver a viable solution to reduce methane emissions from ruminants, launched at COP 22 in Marrakech. The company went on to create the world's first carbon credits from methane mitigation in livestock — CowCredits — building an entirely new category from scratch and pioneering a market mechanism to stimulate demand in the absence of an obvious payer.
mootral.com
A venture studio concept designed to turn bold ideas into reality — providing the infrastructure, mentorship, and capital to launch new businesses from scratch. Where your idea is realized.
nxventures.ioA pioneer in strong, IP-protected, clinically proven nutraceutical technologies — developing science-backed health solutions that bridged the gap between nutrition and medicine.
From doing it ourselves, to helping ventures do it better. Our approach is built on nearly two decades of creating, scaling, and transforming science-led businesses into market leaders.
We help ventures define their vision with precision. Before a single dollar is deployed, we work alongside founders to sharpen strategy, validate assumptions, and build a roadmap grounded in real-world insight.
We provide patient, purpose-aligned capital that gives ventures the runway to build properly — not just quickly. Our investment approach is designed for long-term value creation, not short-term returns.
We don't invest from the sidelines. We embed deeply — contributing governance frameworks, operational expertise, and strategic counsel. We've built ventures from scratch; we know what it takes.
Every venture we support carries purpose. We select partners whose missions align with our commitment to human and planetary health — and we stay committed through the difficult chapters, not just the victories.
Decades of experience building robust governance structures that protect ventures through growth, crisis, and scale.
Real-world wisdom from having built, scaled, and exited multiple ventures across life sciences, technology, and agriculture.
Hands-on support in regulatory affairs, IP strategy, market access, and commercialisation — the hard work that turns science into impact.
Connections to global partners, distributors, regulators, and institutions built over two decades of operating across 50+ countries.
A proven methodology for identifying breakthrough science, protecting intellectual property, and bringing innovations to market.
Frameworks that ensure every venture creates measurable positive outcomes for people, planet, and the bottom line.
While others were just beginning to see the problem, we were already delivering answers. That experience — the scars, the breakthroughs, the lessons learned in the trenches — is what we bring to every venture we support today.
"We create the conditions where others shine — and where impact is scaled with precision."
We apply our capital and expertise in not-for-profit settings, where strategic support can catalyze meaningful and enduring social impact. From helping organizations serve tens of millions of people in crisis zones, to modernizing governance at leading institutions — our aim is the same: to help people thrive.
Supporting organizations like HealthNet TPO to serve tens of millions of people in crisis zones. Providing strategic governance, financial backing, and operational expertise to amplify the reach of frontline humanitarian work.
Modernizing governance at leading institutions in global aid and education. Fostering ethical leadership and building capacity for the next generation of changemakers in health, sustainability, and social enterprise.
Applying our scientific expertise and capital to combat climate change. From pioneering methane reduction in livestock to supporting sustainable agricultural practices, we take urgent action where it matters most.
From 2015 to 2023, Zaluvida was the main financial constituent of HealthNet TPO, a global NGO dedicated to providing healthcare in conflict-affected and fragile states. Our co-founder Carin Beumer assumed the role of Chairman of the Board, bringing strategic governance and operational expertise to an organization that served more than 45 million people across Afghanistan, South Sudan, Burundi, Cambodia, and other crisis zones worldwide.
This partnership exemplifies our belief that business acumen, when applied with care and purpose, can transform the reach and effectiveness of humanitarian work.
45M+
People served in crisis zones
Our desire to change the world by supporting people, their ideas, their wellbeing and their health has been embodied in everything we do since day one. We bring rigor and innovation to where it's needed most — whether that's a biotech lab, a boardroom, or the frontlines of development and humanitarian response.
Applying business mindset and resources to generate lasting positive outcomes for communities.
Understanding and responding to the real needs of people, not just market opportunities.
Building programs and partnerships designed for long-term, self-sustaining change.
Whether you're an entrepreneur with a bold idea, an investor seeking purpose-driven opportunities, or an organization looking for a strategic partner — we'd like to hear from you.
For founders, entrepreneurs, and innovators seeking a strategic partner.
For investors and financial partners interested in our portfolio.
For press, partnerships, general questions about Zaluvida, our ventures, and our work.
For visionary professionals who want to build the future with us.
Zaluvida Ventures Ltd
Invision House, Wilbury Way
Hitchin SG4 0TY
Registered OfficeZaluvida Holdings Pte Ltd
#08-01/02, GB Building
143 Cecil Street
Singapore 069542
Zaluvida Corporate Sdn Bhd
E-16 Plaza Mont Kiara
2 Jalan Kiara
50480 Kuala Lumpur
Zaluvida Corporate AG
Avenue des Uttins 1
1180 Rolle (VD)
Somewhere, it's already tomorrow.
We're just helping it arrive.
